Varian

Are you curious about how other clinics around the world use the Ethos therapy system to perform adaptive radiotherapy? In the “How Do You Adapt?” webinar series, learn what drives clinics to focus on adaptive therapy and how they implement the modality in their current workflow. Check it out at https://bit.ly/4bws2ep

For clinics hoping to improve patient care through the adoption of new technology, success depends on understanding the practice's unique needs. "Implementation planning for technology today must include discussions about a clinic’s scope of services, and what you are planning to do with this technology," says Per Halvorsen, Senior Director of Physics Clinical Operations at Varian. "It comes down to: How do we go about doing this in the best way for our patients?" https://bit.ly/46ss8CF

We’re excited to share that Varian has received FDA 510(k) clearance for the IntelliBlate microwave ablation system! Read the full press release here https://bit.ly/3AcDCy3. Designed to provide clinicians with greater predictability, precision, and control during their procedures, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation. Together with Siemens Healthineers, we are committed to continued development of an integrated approach to microwave ablation that connects innovative therapy technologies and image-guided solutions.

The passionate team members at Varian come from a wide range of technical and clinical backgrounds, but we are all united in our mission to enhance patient outcomes and help build a world without fear of cancer.     "What I’ve found most rewarding about working at Varian is the combination of bench-depth and willingness for collaboration," says Per Halvorsen, the recipient of this year's Marvin M.D. Williams Professional Achievement Award recognizing an outstanding career in medical physics. "Simply put, the access to expert knowledge on nearly any radiation oncology topic is unmatched by any setting I’ve worked in during my 33-year clinical career."     Are you a clinical physicist or dosimetrist interested in joining the team? https://bit.ly/3YeSXrU

Yesterday we had the pleasure of hosting Government of Alberta Minister of Technology and Innovation Nate Glubish and his team at our Palo Alto headquarters. The day was full of passionate discussion about how #government and #business experts can support each other in the never-ending quest to improve patient outcomes. From bolstering the training pipeline of medical experts, to leveraging #ArtificialIntelligence to reduce patient wait times, we're confident the path to progress is through meaningful collaboration. Thank you, Minister Glubish and your team, for your thought partnership and commitment to improving the lives of your constituents.

At Varian, we are dedicated to fostering a culture of diversity, equity, and inclusion, and our recent sponsorship and participation in the #AAPM2024 Women in Physics Luncheon is a testament to that commitment. By empowering women in physics, we aim to foster innovation and contribute to a more equitable and inclusive scientific community. We are proud to have been a part of this inspiring event and look forward to celebrating the achievements of these incredible female scientists. 

We’re excited to share that Varian has received FDA 510(k) clearance for new functionality to its Ethos therapy system! Read the full release here https://bit.ly/3y4nSg7. Introducing a streamlined workflow for daily treatment adaptation across more areas of the body, and providing greater connectivity to patient data, this latest generation reduces complexity, making it easier to implement adaptive, personalized radiotherapy. Ethos 2.0 equips clinical teams with a versatile, comprehensive solution, and optimizes clinical and operational efficiencies with several new and updated features.

It's official - The Varian teams have arrived in beautiful and sunny Los Angeles for #AAPM2024!   We hope you'll stop by to say hi and learn about the latest in cancer care solutions - like Eclipse v18.0, the gateway to future innovation, unlocking a whole new level of precision, efficiency, and consistency in treatment planning.

Congratulations to the National Taiwan University Cancer Center (NTUCC) for completing their HyperArc Clinical Implementation program - designed to enable simplicity, consistency and confidence during stereotactic radiosurgery. “The great thing is that the program helped us review the entire clinical process and optimize every small detail from CT-simulation to plan quality assurance," says Ms. Chia-Jung Wu, Chief Physicist of NTUCC. "We are looking forward to the operational results of this program." We've no doubt that your newly optimized clinical pathway will help you deliver best-in-class to even more patients. #TogetherWeFight 

As the number of people living with cancer rises sharply, there will be an enormous burden on care professionals and our health systems. We believe that digital innovations, including AI, will be key to facing this challenge.     "When you get a cancer diagnosis, every minute counts. But cancer is complex, treatment is complex. No two cancers are alike because no two patients are alike," says Ashley Smith, President of Multi-Disciplinary Oncology at Varian.     "AI is speeding up the cumbersome parts of the process. At every step along the way, it aims to increase efficiency and personalization. Our goal is to help clinicians provide the right treatment at the right time and to ultimately help create a world where people don’t have to fear cancer."